Skip to main content
. 2022 Feb 16;258:126993. doi: 10.1016/j.micres.2022.126993

Table 1.

The application of SARS-CoV-2 pseudovirus.

Application Packaging system Reporter gene Reference
Neutralizing Antibody Assay VSV, HIV Luciferase (Cao et al., 2020, Lei et al., 2020)
Vaccine HIV, VSV, MLV Luciferase, GFP (Erasmus and Fuller, 2020, Ma et al., 2020, Zhang et al., 2020, Sanchez-Felipe et al., 2021, Vogel et al., 2021)
Screen of Entry Inhibitors HIV, MLV Luciferase (Zhu et al., 2020, Joseph et al., 2021, Xu et al., 2021)
Mechanisms of Virus Entry VSV, MLV Luciferase (Daly et al., 2020, Yang et al., 2020b, Ou et al., 2021)
Variants of SARS-CoV-2 HIV, VSV Luciferase (Hoffmann et al., 2021, Hu et al., 2021, Wang et al., 2021c)